Hormonal status modulates natural killer activity (1999)
- Authors:
- USP affiliated authors: CASTRO, FABIOLA ATTIE DE - FCFRP ; FERRIANI, RUI ALBERTO - FMRP ; VOLTARELLI, JULIO CESAR - FMRP
- Unidades: FCFRP; FMRP
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: Brazilian for Immunology
- Publisher place: Águas de Lindóia
- Date published: 1999
- Source:
- Título do periódico: Summary
- Conference titles: Annual Meeting of the Brazilian Society for Immunology
-
ABNT
SOUZA, S. S. et al. Hormonal status modulates natural killer activity. 1999, Anais.. Águas de Lindóia: Brazilian for Immunology, 1999. . Acesso em: 19 set. 2024. -
APA
Souza, S. S., Castro, F. A. de, Palma, P. V. B., Morais, F. R., Ferriani, R. A., & Voltarelli, J. C. (1999). Hormonal status modulates natural killer activity. In Summary. Águas de Lindóia: Brazilian for Immunology. -
NLM
Souza SS, Castro FA de, Palma PVB, Morais FR, Ferriani RA, Voltarelli JC. Hormonal status modulates natural killer activity. Summary. 1999 ;[citado 2024 set. 19 ] -
Vancouver
Souza SS, Castro FA de, Palma PVB, Morais FR, Ferriani RA, Voltarelli JC. Hormonal status modulates natural killer activity. Summary. 1999 ;[citado 2024 set. 19 ] - Influence of menstrual cycle on NK activity
- Influence of menstrual cycle on NK activity
- Immunological effects of interferon-alpha on chronic myelogenous Leukemia
- Alterações imunológicas associadas ao uso do interferon-alfa na leucemia mielóide crônica
- Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation
- Fas/Fas-ligand expression on lymphocytes subsets in chronic myelogenous leukemia patients after allogenic
- Immunological follow-up of patients with chronic myelogenous leukemia treated with 'alfa'-IFN
- Immunotherapy of hematological neoplasms
- Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after allogenic bone marrow transplantation
- FAS and FASL expression on chronic myelogenous leukemia: a better understanding to disease progress
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas